General | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Comparison | ||||||||||||||||||||||||||||
|
Why Is Catalent (CTLT) Up 0.4% Since Last Earnings Report? | zacks.com • |
Catalent stockholders approve deal with Novo Holdings | reuters.com • |
Catalent Stockholders Approve Transaction with Novo Holdings | businesswire.com • |
Surely Wines Appoints Brandon Joldersma as New CEO | businesswire.com • |
Catalent's (CTLT) Latest Partnership to Boost Clinical Trials | zacks.com • |
Catalent (CTLT) Q3 Earnings Lag Estimates, Gross Margin Up | zacks.com • |
Date | For | Estimate | Reported | Surprise | surprise % |
---|---|---|---|---|---|
2024-05-08 | 2024-03 | 0.24 | -0.06 | -0.3 | -125.00% |
2024-02-09 | 2023-12 | -0.03 | -0.24 | -0.21 | -700.00% |
2023-11-15 | 2023-09 | -0.13 | -0.1 | 0.03 | 23.08% |
2023-08-29 | 2023-06 | 0.1 | 0.09 | -0.01 | -10.00% |
2023-02-07 | 2022-12 | 0.72 | 0.67 | -0.05 | -6.94% |
2022-11-01 | 2022-09 | 0.55 | 0.34 | -0.21 | -38.18% |
Date | Firm | Action | From | To |
---|---|---|---|---|
2023-09-28 | Barclays | Upgrade | Equal-Weight | Equal-Weight |
2023-09-04 | Argus Research | Upgrade | Hold | Buy |
2023-08-31 | Barclays | Upgrade | Equal-Weight | Equal-Weight |
2023-08-30 | RBC Capital | Upgrade | Outperform | Outperform |
2023-08-30 | B of A Securities | Upgrade | Underperform | Underperform |
2023-08-29 | RBC Capital | Upgrade | Outperform | Outperform |
Date | Name | Relation | Quantity | Description |
---|---|---|---|---|
2023-10-26 | BALACHANDRAN MADHAVEN | Director | 27.44K | Stock Award(Grant) |
2023-10-26 | BARBER MICHAEL J | Director | 13.39K | Stock Award(Grant) |
2023-10-26 | CLASSON ROLF A | Director | 43.32K | Stock Award(Grant) |
2023-12-07 | GENNADIOS ARISTIPPOS | Officer | 96.50K | Stock Award(Grant) |
2024-03-14 | GUNTHER SCOTT G | Officer | 29.51K | Sale |
2024-01-15 | HATZFELD MICHAEL JR. | Officer | 7.91K | Stock Award(Grant) |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-06-29 | Vanguard Group Inc | 20.10M | 871.64M | 11.15% |
2023-06-29 | Capital World Investors | 15.96M | 692.04M | 8.85% |
2023-06-29 | Blackrock Inc. | 14.92M | 646.88M | 8.28% |
2023-06-29 | Janus Henderson Group PLC | 14.74M | 639.02M | 8.18% |
2023-06-29 | T. Rowe Price Investment Management, Inc. | 13.43M | 582.49M | 7.45% |
2023-06-29 | Nomura Holdings Inc. | 8.44M | 365.80M | 4.68% |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-06-29 | Price (T.Rowe) Mid Cap Growth Fund | 5.89M | 255.34M | 3.27% |
2023-06-29 | Vanguard Total Stock Market Index Fund | 5.33M | 231.19M | 2.96% |
2023-09-29 | Capital World Growth and Income Fund | 4.68M | 212.90M | 2.59% |
2023-06-29 | Vanguard 500 Index Fund | 4.29M | 186.08M | 2.38% |
2023-06-29 | Janus Henderson Contrarian Fund | 4.21M | 182.67M | 2.34% |
2023-06-29 | Growth Fund Of America Inc | 3.61M | 156.32M | 2.00% |
I start investment with a little capital of $500 I made over $1,000, within 7 working days of trade with Mrs Barbara J Lawrence . I directly recommend you to reach her out on Facebook & WhatsApp +447475864378.
$68-$69 at open
Big gap to fill
Short here.. without Moderna deal, this would go down to $30..
Interest rates unlikely to come down in early next year… market rally may not last long
Dump it …
Back to $67-$68.. no indication of Fed interest cut… in fact small hikes to continue
Down to $65 in an hour
Closed too early…
However, Citi is cautious about a potential deal due to concerns about strategic fit and Danaher’s (DHR) prior remarks on acquisitions in the CRO and CDMO field.
Buyers exhausted… seller will dump now
News a day before results… results must be poor
News a day before results… results must be poor
Back to $60 soon
Nothing is known… could be low ball offer… could be no offer
Sell now… way too high…